RT Journal Article
SR Electronic
T1 Can Educational Institutions Reopen for In-Person Classes Safely Amid the Covid-19 Pandemic?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.04.20188680
DO 10.1101/2020.09.04.20188680
A1 Kumar Mukherjee, Ujjal
A1 Bose, Subhonmesh
A1 Ivanov, Anton
A1 Souyris, Sebastian
A1 Seshadri, Sridhar
A1 Sridhar, Padmavati
A1 Watkins, Ronald
A1 Xu, Yuqian
YR 2020
UL http://medrxiv.org/content/early/2020/09/07/2020.09.04.20188680.abstract
AB Can educational institutions open up safely amid COVID-19? We build an epidemiological model to investigate the strategies necessary for institutions to reopen. The four measures that are most relevant for in-person opening are: (i) wide-spread rapid testing, possibly saliva-based, (ii) enforcement of mask wearing, (iii) social distancing, and (iv) contact tracing. We demonstrate that institutions need to test at a relatively high level (e.g., at least once every week) in the initial phases of reopening. Contact tracing is relatively more important when the positivity rate from random testing is relatively low, which is likely during the initial phases. A Bayesian adaptive testing strategy based on positivity rates can help institutions optimally manage the costs and risks of reopening. This paper contributes to the nascent literature on combating the COVID-19 pandemic and is especially relevant for large-scale organizations. This work is motivated and guided by the SHIELD program of UIUC.Competing Interest StatementThe authors have declared no competing interest.Funding Statementc3.ai COVID-19 research funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:None required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe simulation codes will be made available on request.